{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:04:19Z","timestamp":1749614659673,"version":"3.41.0"},"reference-count":29,"publisher":"Gobierno de Navarra","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2018,12,26]]},"DOI":"10.23938\/assn.0381","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T08:14:07Z","timestamp":1542183247000},"page":"339-346","source":"Crossref","is-referenced-by-count":3,"title":["Drug-related mortality among inpatients admitted in Internal Medicine"],"prefix":"10.23938","volume":"41","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"BOEKER EB, DE BOER M, KIEWIET JJ, LIE-A-HUEN L, DIJKGRAAF MG, BOERMEESTER MA. Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature. BMC Health Serv Res 2013; 13: 364. doi: 10.1186\/1472-6963-13-364.","DOI":"10.1186\/1472-6963-13-364"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/s1553-7250(12)38016-1","article-title":"The costs of adverse drug events in community hospitals","volume":"38","author":"HUG","year":"2012","unstructured":"2. HUG BL, KEOHANE C, SEGER DL, YOON C, BATES DW. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf 2012; 38: 120-126.","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1111\/jgs.13054","article-title":"Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia","volume":"62","author":"KALISCH ELLETT","year":"2014","unstructured":"3. KALISCH ELLETT LM, PRATT NL, RAMSAY EN, BARRATT JD, ROUGHEAD EE. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J Am Geriatr Soc 2014; 62: 1916-1922.","journal-title":"J Am Geriatr Soc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00228-013-1563-z","article-title":"Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay a systematic review","volume":"69","author":"KHAN","year":"2013","unstructured":"4. KHAN LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay a systematic review. Eur J Clin Pharmacol 2013; 69: 1985-1996.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. LEPORINI C, DE SARRO G, RUSSO E. Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf 2014; 13 (Suppl 1): 41-55.","DOI":"10.1517\/14740338.2014.947260"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-004-0830-4","article-title":"The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals","volume":"60","author":"BLIX","year":"2004","unstructured":"6. BLIX HS, VIKTIL KK, REIKVAM A, MOGER TA, HJEMAAS BJ, PRETSCH P et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60: 651-658.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2710.2006.00744.x","article-title":"Adverse drug reactions in hospital in-patients: a pilot study","volume":"31","author":"DAVIES","year":"2006","unstructured":"7. DAVIES EC, GREEN CF, MOTTRAM DR, PIRMOHAMED M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335-341.","journal-title":"J Clin Pharm Ther"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. DAVIES EC, GREEN CF, TAYLOR S, WILLIAMSON PR, MOTTRAM DR, PIRMOHAMED M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS one 2009; 4: e4439. doi: 10.1371\/journal.pone.0004439.","DOI":"10.1371\/journal.pone.0004439"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1001\/archinte.161.19.2317","article-title":"Drug-related deaths in a department of internal medicine","volume":"161","author":"EBBESEN","year":"2001","unstructured":"9. EBBESEN J, BUAJORDET I, ERIKSSEN J, BR\u00d8RS O, HILBERG T, SVAAR H et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001; 161: 2317-2323.","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00228-002-0501-2","article-title":"Drug-related deaths in a university central hospital","volume":"58","author":"JUNTTI-PATINEN L","year":"2002","unstructured":"10. JUNTTI-PATINEN L, NEUVONEN PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002; 58: 479-482.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/ajhp\/58.14.1317","article-title":"Potential risks and prevention, part 1: fatal adverse drug events","volume":"58","author":"KELLY","year":"2001","unstructured":"11. KELLY WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health Syst Pharm 2001; 58: 1317-1324.","journal-title":"Am J Health Syst Pharm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"12001205","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"LAZAROU","year":"1998","unstructured":"12. LAZAROU J, POMERANZ BH, COREY PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 12001205.","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","article-title":"Serious adverse drug events reported to the Food and Drug Administration 1998-2005","volume":"167","author":"MOORE","year":"2007","unstructured":"13. MOORE TJ, COHEN MR, FURBERG CD. Serious adverse drug events reported to the Food and Drug Administration 1998-2005. Arch Intern Med 2007; 167: 1752-1759.","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/bcp.12567","article-title":"Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey","volume":"80","author":"MOUTON","year":"2015","unstructured":"14. MOUTON JP, MEHTA U, PARRISH AG. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharmacol 2015; 80: 818-826.","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.2146\/ajhp060641","article-title":"Admissions to amedical intensive care unit related to adverse drug reactions","volume":"64","author":"RIVKIN","year":"2007","unstructured":"15. RIVKIN A. Admissions to amedical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 2007; 64: 1840-1843.","journal-title":"Am J Health Syst Pharm"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","article-title":"Incidence of fatal adverse drug reactions: a population based study","volume":"65","author":"WESTER","year":"2008","unstructured":"16. WESTER K, J\u00d6NSSON AK, SPIGSET O, DRUID H, H\u00c4GG S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008; 65: 573-579.","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s002280000158","article-title":"Gallen","volume":"56","author":"ZOPPI","year":"2000","unstructured":"17. ZOPPI M, BRAUNSCHWEIG S, KUENZI UP, MAIBACH R, HOIGN\u00c9 R. Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne\/St. Gallen. Eur J Clin Pharmacol 2000; 56: 427-430.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. PUCHE CA\u00d1AS E, LUNA DEL CASTILLO JD. Adverse drug reactions in patients visiting a general hospital: a meta-analysis of results. An Med Interna 2007; 24: 574-578.","DOI":"10.4321\/S0212-71992007001200003"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5414\/CPP47596","article-title":"Prevalence of fatal adverse drug reactions in hospitalized patients","volume":"47","author":"PARDO CABELLO","year":"2009","unstructured":"19. PARDO CABELLO AJ, GONZ\u00c1LEZ CONTRERAS LG, MANZANO GAMERO MV, G\u00d3MEZ JIM\u00c9NEZ FJ, PUCHE E. Prevalence of fatal adverse drug reactions in hospitalized patients. Int J Clin Pharmacol Ther 2009; 47: 596-602.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref19","unstructured":"20. American Society of Health-System Pharmacists. Best practices for health-system pharmacy: positions and practice standards of ASHP 1999-2000. Bethesda, EE. UU. 1999. ISBN: 1-979907-99-2."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"NARANJO","year":"1981","unstructured":"21. NARANJO CA, BUSTO U, SELLERS EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.","journal-title":"Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.rce.2017.07.008","article-title":"Eight years of hospitalisation in Internal Medicine Units (2007-2014)","volume":"217","author":"ZAPATERO-GAVIRIA","year":"2017","unstructured":"22. ZAPATERO-GAVIRIA A, BARBA-MART\u00cdN R, CANORA-LEBRATO J, FERN\u00c1NDEZ-P\u00c9REZ C, GOMEZ-HUELGAS R, BERNAL-SOBRINO JL et al. RECALMIN II. Eight years of hospitalisation in Internal Medicine Units (2007-2014). What has changed? Rev Clin Esp 2017; 217: 446-453.","journal-title":"What has changed? Rev Clin Esp"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa021266","article-title":"Sex-based differences in the effect of digoxin for the treatment of heart failure","volume":"347","author":"RATHORE","year":"2002","unstructured":"23. RATHORE SS, WANG Y, KRUMHOLZ HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347: 1403-1411.","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jamda.2010.12.099","article-title":"Risk factors for aspiration pneumonia in frail older people: a systematic literature review","volume":"12","author":"VAN DER MAAREL-WIERINK","year":"2011","unstructured":"24. VAN DER MAAREL-WIERINK CD, VANOBBERGEN JN, BRONKHORST EM, SCHOLS JM, DE BAAT C. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc 2011; 12: 344-354.","journal-title":"J Am Med Dir Assoc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1368-5031.2004.0088.x","article-title":"Psychopharmacohazardology: major hazards of the new generation of psychotherapeutic drugs","volume":"58","author":"ZETIN","year":"2004","unstructured":"25. ZETIN M. Psychopharmacohazardology: major hazards of the new generation of psychotherapeutic drugs. Int J Clin Pract 2004; 58: 58-68.","journal-title":"Int J Clin Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2001.00892.x","article-title":"Fatal adverse drug events: the paradox of drug treatment","volume":"250","author":"BUAJORDET","year":"2001","unstructured":"26. BUAJORDET I, EBBESEN J, ERIKSSEN J, BR\u00d8RS O, HILBERG T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327-341.","journal-title":"J Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. LESSING C, SCHMITZ A, ALBERS B, SCHRAPPE M. Impact of sample size on variation of adverse events and preventable adverse events: systematic review on epidemiology and contributing factors. Qual Saf Health Care 2010; 19: e24. doi: 10.1136\/qshc.2008.031435.","DOI":"10.1136\/qshc.2008.031435"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: detection and classification methods","volume":"13","author":"MORIMOTO","year":"2004","unstructured":"28. MORIMOTO T, GANDHI TK, SEGER AC, HSIEH TC, BATES DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13: 306-314.","journal-title":"Qual Saf Health Care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1365-2125.2000.00204.x","article-title":"The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards","volume":"49","author":"LAU","year":"2000","unstructured":"29. LAU HS, FLORAX C, PORSIUS AJ, DE BOER A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000; 49: 597-603.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/65691\/41975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:02:50Z","timestamp":1749535370000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/65691\/41975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,26]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0381","relation":{},"ISSN":["1137-6627"],"issn-type":[{"type":"print","value":"1137-6627"}],"subject":[],"published":{"date-parts":[[2018,12,26]]}}}